Thermo Fisher Scientific Inc. (TMO) trades at a trailing P/E of 28.0, forward P/E of 21.4. Trailing earnings yield is 3.57%, forward earnings yield 4.67%. PEG 3.84. Graham Number is $239.19.
Criteria proven by this page:
Overall SharesGrow Score: 63/100 with 3/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | 27.6 | 8.54 | 2.59 | 3.05 | 0.43% |
| 2017 | 33.7 | 3.32 | 2.95 | 3.59 | 0.32% |
| 2018 | 30.6 | 1.03 | 3.26 | 3.69 | 0.30% |
| 2019 | 35.2 | 1.33 | 4.38 | 5.09 | 0.23% |
| 2020 | 28.9 | 0.39 | 5.35 | 5.73 | 0.18% |
| 2021 | 34.0 | 1.56 | 6.44 | 6.70 | 0.15% |
| 2022 | 31.1 | -3.24 | 4.91 | 4.81 | 0.21% |
| 2023 | 34.2 | -2.75 | 4.38 | 4.78 | 0.26% |
| 2024 | 31.4 | 4.64 | 4.01 | 4.63 | 0.29% |
| 2025 | 32.3 | 4.51 | 4.08 | 4.89 | 0.29% |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $5.09 | $18.27B | $2.02B | 11.1% |
| 2017 | $5.59 | $20.92B | $2.23B | 10.6% |
| 2018 | $7.24 | $24.36B | $2.94B | 12.1% |
| 2019 | $9.17 | $25.54B | $3.7B | 14.5% |
| 2020 | $15.98 | $32.22B | $6.38B | 19.8% |
| 2021 | $19.46 | $39.21B | $7.73B | 19.7% |
| 2022 | $17.64 | $44.92B | $6.95B | 15.5% |
| 2023 | $15.45 | $42.86B | $6B | 14% |
| 2024 | $16.53 | $42.88B | $6.34B | 14.8% |
| 2025 | $17.74 | $44.56B | $6.74B | 15.1% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $24.58 | $24.18 – $25.78 | $46.92B | $46.33B – $47.17B | 17 |
| 2027 | $26.85 | $26.42 – $28.25 | $49.3B | $48.61B – $50.08B | 17 |
| 2028 | $29.74 | $28.31 – $31.08 | $52.67B | $52.5B – $52.61B | 4 |
| 2029 | $32.97 | $32.34 – $33.86 | $55.65B | $54.83B – $56.8B | 2 |
| 2030 | $36.24 | $35.54 – $37.21 | $57.24B | $56.39B – $58.42B | 2 |
